Regular-fat dairy and human health: A synopsis of symposia presented in Europe and North America (2014-2015)

Nutrients

Volumn 8, Issue 8, 2016, Pages

  Astrup, Arne ^a   Rice Bradley, Beth H ^b   Thomas Brenna, J ^c   Delplanque, Bernadette ^d   Ferry, Monique ^e   Torres Gonzale, Moises ^f  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Foodsense   (United States)

^c Department of Obstetrics Gynecology   (United States)

^d CNRS   (France)

^e University Sorbonne Paris Cité and OST Hcéres   (France)

^f National Dairy Council   (United States)

Author keywords

Cardiovascular disease; Cheese; Dairy; Fat; Infant formula; Milk; Type 2 diabetes; Yogurt

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MILK FAT; MONOUNSATURATED FATTY ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; YOGHURT; FAT INTAKE;

BREAST MILK; CARDIOMETABOLIC RISK; CEREBROVASCULAR ACCIDENT; CHEESE; CHOLESTEROL BLOOD LEVEL; DAIRY PRODUCT; DIASTOLIC BLOOD PRESSURE; ENTEROCOLITIS; FAT INTAKE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOW FAT DIET; MEDITERRANEAN DIET; META ANALYSIS (TOPIC); METABOLIC DISORDER; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN; ADULT; ADVERSE EFFECTS; ANALYSIS; ANIMAL; CARDIOVASCULAR DISEASES; CHILD; CHILD NUTRITION; DIABETES MELLITUS, TYPE 2; EUROPE; EVIDENCE BASED MEDICINE; FUNCTIONAL FOOD; HEALTHY DIET; INFANT; INFANT NUTRITION; MEDICAL RESEARCH; NORTH AMERICA; NUTRITION POLICY; NUTRITIONAL SCIENCE; ORGANIZATION; OVERWEIGHT; PROCEDURES; PSYCHOPHYSIOLOGY; RISK FACTOR; THERAPEUTIC USE; TRENDS;

ADULT; ANIMALS; BIOMEDICAL RESEARCH; CARDIOVASCULAR DISEASES; CHILD; CHILD NUTRITIONAL PHYSIOLOGICAL PHENOMENA; CONGRESSES AS TOPIC; DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIETARY FATS; EUROPE; EVIDENCE-BASED MEDICINE; FUNCTIONAL FOOD; HEALTHY DIET; HUMANS; INFANT; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NORTH AMERICA; NUTRITION POLICY; NUTRITIONAL SCIENCES; OVERWEIGHT; RISK FACTORS; SATIETY RESPONSE;

EID: 85015584553     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8080463     Document Type: Review

References (131)

1. Kratz, M. Introduction. In Whole-Milk Dairy Foods in Nutrition and Health: An Evaluation of the Current State of the Science, Proceedings of the American Society for Nutrition Annual Meeting Held in Conjunction with Experimental Biology, Boston, MA, USA, 27 March 2015. Available online: http://scientificsessions.nutrition.org/2015/satellitesessions/dairy/ (accessed on 14 July 2016).
2. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. Available online: http://health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietaryguidelines-advisory-committee.pdf (accessed on 27 July 2016).
3. Bad Fats. Available online: http://www.world-heart-federation.org/cardiovascular-health/cardiovasculardisease-risk-factors/diet/bad-fats/ (accessed on 27 July 2016).
4. Dietary Guidelines for Americans, 2015-2020. Available online: http://health.gov/dietaryguidelines/2015/ guidelines/ (accessed on 27 July 2016).
5. O’Donnell, A.M.; Spatny, K.P.; Vicini, J.L.; Bauman, D.E. Survey of the fatty acid composition of retail milk differing in label claims based on production management practices. J. Dairy Sci. 2010, 93, 1918-1925. [CrossRef] [PubMed]
6. German, J.B.; Gibson, R.A.; Krauss, R.M.; Nestel, P.; Lamarche, B.; van Staveren, W.A.; Steijns, J.M.; de Groot, L.C.; Lock, A.L.; Destaillats, F. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur. J. Nutr. 2009, 48, 191-203. [CrossRef] [PubMed]
7. Mensink, R.P.; Zock, P.L.; Kester, A.D.; Katan, M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146-1155. [PubMed]
8. DeGoma, E.M.; Knowles, J.W.; Angeli, F.; Budoff, M.J.; Rader, D.J. The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol. Rev. 2012, 20, 118-129. [CrossRef] [PubMed]
9. Kratz, M.; Baars, T.; Guyenet, S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur. J. Nutr. 2013, 52, 1-24. [CrossRef] [PubMed]
10. Brenna, J.T. Current dietary fat recommendations and the bioactive fatty acids of milkfat. In Proceedings of the American Society for Nutrition Annual Meeting Held in Conjunction with Experimental Biology, Boston, MA, USA, 27 March 2015. Available online: http://scientificsessions.nutrition.org/2015/satellitesessions/ dairy/ (accessed on 14 July 2016).
11. Ramsden, C.E.; Zamora, D.; Leelarthaepin, B.; Majchrzak-Hong, S.F.; Faurot, K.R.; Suchindran, C.M.; Ringel, A.; Davis, J.M.; Hibbeln, J.R. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: Evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013, 346, e8707. [CrossRef] [PubMed]
12. Jakobsen, M.U.; Overvad, K.; Dyerberg, J.; Heitmann, B.L. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int. J. Epidemiol. 2008, 37, 173-182. [CrossRef] [PubMed]
13. Stender, S.; Astrup, A.; Dyerberg, J. Ruminant and industrially produced trans fatty acids: Health aspects. Food Nutr. Res. 2008, 52. [CrossRef] [PubMed]
14. Lock, A.L.; Horne, C.A.; Bauman, D.E.; Salter, A.M. Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters. J. Nutr. 2005, 135, 1934-1939. [PubMed]
15. Ip, C.; Scimeca, J.A.; Thompson, H.J. Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer 1994, 74, 1050-1054. [PubMed]
16. Terpstra, A.H. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: An overview of the literature. Am. J. Clin. Nutr. 2004, 79, 352-361. [PubMed]
17. Tricon, S.; Yaqoob, P. Conjugated linoleic acid and human health: A critical evaluation of the evidence. Curr. Opin. Clin. Nutr. Metab. Care 2006, 9, 105-110. [CrossRef] [PubMed]
18. Gebauer, S.K.; Destaillats, F.; Dionisi, F.; Krauss, R.M.; Baer, D.J. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: A double-blind, randomized controlled trial. Am. J. Clin. Nutr. 2015, 102, 1339-1346. [CrossRef] [PubMed]
19. Motard-Belanger, A.; Charest, A.; Grenier, G.; Paquin, P.; Chouinard, Y.; Lemieux, S.; Couture, P.; Lamarche, B. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am. J. Clin. Nutr. 2008, 87, 593-599. [PubMed]
20. Lacroix, E.; Charest, A.; Cyr, A.; Baril-Gravel, L.; Lebeuf, Y.; Paquin, P.; Chouinard, P.Y.; Couture, P.; Lamarche, B. Randomized controlled study of the effect of a butter naturally enriched in trans fatty acids on blood lipids in healthy women. Am. J. Clin. Nutr. 2012, 95, 318-325. [CrossRef] [PubMed]
21. Ran-Ressler, R.R.; Sim, D.; O’Donnell-Megaro, A.M.; Bauman, D.E.; Barbano, D.M.; Brenna, J.T. Branched chain fatty acid content of United States retail cow’s milk and implications for dietary intake. Lipids 2011, 46, 569-576. [CrossRef] [PubMed]
22. Kaneda, T. Iso-and anteiso-fatty acids in bacteria: Biosynthesis, function, and taxonomic significance. Microbiol. Rev. 1991, 55, 288-302. [PubMed]
23. Ran-Ressler, R.R.; Devapatla, S.; Lawrence, P.; Brenna, J.T. Branched chain fatty acids are constituents of the normal healthy newborn gastrointestinal tract. Pediatr. Res. 2008, 64, 605-609. [CrossRef] [PubMed]
24. Ran-Ressler, R.R.; Khailova, L.; Arganbright, K.M.; Adkins-Rieck, C.K.; Jouni, Z.E.; Koren, O.; Ley, R.E.; Brenna, J.T.; Dvorak, B. Branched chain fatty acids reduce the incidence of necrotizing enterocolitis and alter gastrointestinal microbial ecology in a neonatal rat model. PLoS ONE 2011, 6, e29032. [CrossRef] [PubMed]
25. Torres-Gonzalez, M. Clinical evidence for saturated fat and full-fat dairy foods on lipid biomarkers. In Proceedings of the American Society forNutrition Annual Meeting Held in Conjunction with Experimental Biology, Boston, MA, USA, 27 March 2015. Available online: http://scientificsessions.nutrition.org/2015/satellitesessions/dairy/ (accessed on 14 July 2016).
26. Kritchevsky, D. History of recommendations to the public about dietary fat. J. Nutr. 1998, 128, 449S-452S. [PubMed]
27. Reiser, R. Oversimplification of diet: Coronary heart disease relationships and exaggerated diet recommendations. Am. J. Clin. Nutr. 1978, 31, 865-875. [PubMed]
28. De Lorgeril, M.; Salen, P. Dietary prevention of coronary heart disease: The Lyon diet heart study and after. World Rev. Nutr. Diet. 2005, 95, 103-114. [PubMed]
29. Poss, J.; Custodis, F.; Werner, C.; Weingartner, O.; Bohm, M.; Laufs, U. Cardiovascular disease and dyslipidemia: Beyond LDL. Curr. Pharm. Des. 2011, 17, 861-870. [CrossRef] [PubMed]
30. Navab, M.; Reddy, S.T.; Van Lenten, B.J.; Fogelman, A.M. HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nat. Rev. Cardiol. 2011, 8, 222-232. [CrossRef] [PubMed]
31. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143-3421.
32. Lamarche, B.; Lemieux, I.; Despres, J.P. The small, dense LDL phenotype and the risk of coronary heart disease: Epidemiology, patho-physiology and therapeutic aspects. Diabetes Metab. 1999, 25, 199-211. [PubMed]
33. Alaupovic, P. The concept of apolipoprotein-defined lipoprotein families and its clinical significance. Curr. Atheroscler. Rep. 2003, 5, 459-467. [CrossRef] [PubMed]
34. Krauss, R.M. Lipoprotein subfractions and cardiovascular disease risk. Curr. Opin. Lipidol. 2010, 21, 305-311. [CrossRef] [PubMed]
35. Mora, S.; Szklo, M.; Otvos, J.D.; Greenland, P.; Psaty, B.M.; Goff, D.C., Jr.; O’Leary, D.H.; Saad, M.F.; Tsai, M.Y.; Sharrett, A.R. LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2007, 192, 211-217. [CrossRef] [PubMed]
36. St-Pierre, A.C.; Cantin, B.; Dagenais, G.R.; Mauriege, P.; Bernard, P.M.; Despres, J.P.; Lamarche, B. Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 553-559. [CrossRef] [PubMed]
37. Musunuru, K.; Orho-Melander, M.; Caulfield, M.P.; Li, S.; Salameh, W.A.; Reitz, R.E.; Berglund, G.; Hedblad, B.; Engstrom, G.; Williams, P.T. et al. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 2009, 29, 1975-1980. [CrossRef] [PubMed]
38. Berneis, K.K.; Krauss, R.M. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 2002, 43, 1363-1379. [CrossRef] [PubMed]
39. Kathiresan, S.; Otvos, J.D.; Sullivan, L.M.; Keyes, M.J.; Schaefer, E.J.; Wilson, P.W.; D’Agostino, R.B.; Vasan, R.S.; Robins, S.J. Increased small low-density lipoprotein particle number: A prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 2006, 113, 20-29. [CrossRef] [PubMed]
40. Magkos, F.; Mohammed, B.S.; Mittendorfer, B. Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women. Int. J. Obes. (Lond.) 2008, 32, 1655-1664. [CrossRef] [PubMed]
41. Nikolic, D.; Katsiki, N.; Montalto, G.; Isenovic, E.R.; Mikhailidis, D.P.; Rizzo, M. Lipoprotein subfractions in metabolic syndrome and obesity: Clinical significance and therapeutic approaches. Nutrients 2013, 5, 928-948. [CrossRef] [PubMed]
42. Rader, D.J.; Tall, A.R. The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat. Med. 2012, 18, 1344-1346. [CrossRef] [PubMed]
43. Austin, M.A. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 1991, 11, 2-14. [CrossRef] [PubMed]
44. Miller, M.; Stone, N.J.; Ballantyne, C.; Bittner, V.; Criqui, M.H.; Ginsberg, H.N.; Goldberg, A.C.; Howard, W.J.; Jacobson, M.S.; Kris-Etherton, P.M. et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2011, 123, 2292-2333. [CrossRef] [PubMed]
45. Siri-Tarino, P.W.; Chiu, S.; Bergeron, N.; Krauss, R.M. Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment. Annu. Rev. Nutr. 2015, 35, 517-543. [CrossRef] [PubMed]
46. Pearson, T.A.; Mensah, G.A.; Alexander, R.W.; Anderson, J.L.; Cannon, R.O., 3rd; Criqui, M.; Fadl, Y.Y.; Fortmann, S.P.; Hong, Y.; Myers, G.L. et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107, 499-511. [PubMed]
47. Ridker, P.M.; Hennekens, C.H.; Buring, J.E.; Rifai, N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000, 342, 836-843. [CrossRef] [PubMed]
48. Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; de Jesus, J.M.; Houston Miller, N.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E. et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2014, 63, 2960-2984. [CrossRef] [PubMed]
49. Lipsy, R.J. The National Cholesterol Education Program Adult Treatment Panel III guidelines. J. Manag. Care Pharm. 2003, 9, 2-5. [PubMed]
50. Mozaffarian, D.; Micha, R.; Wallace, S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010, 7, e1000252. [CrossRef] [PubMed]
51. Ramsden, C.E.; Zamora, D.; Majchrzak-Hong, S.; Faurot, K.R.; Broste, S.K.; Frantz, R.P.; Davis, J.M.; Ringel, A.; Suchindran, C.M.; Hibbeln, J.R. Re-evaluation of the traditional diet-heart hypothesis: Analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016, 353, i1246. [CrossRef] [PubMed]
52. De Lorgeril, M.; Salen, P.; Martin, J.L.; Monjaud, I.; Delaye, J.; Mamelle, N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study. Circulation 1999, 99, 779-785. [CrossRef] [PubMed]
53. Obarzanek, E.; Sacks, F.M.; Vollmer, W.M.; Bray, G.A.; Miller, E.R., 3rd; Lin, P.H.; Karanja, N.M.; Most-Windhauser, M.M.; Moore, T.J.; Swain, J.F. et al. Effects on blood lipids of a blood pressure-lowering diet: The Dietary Approaches to Stop Hypertension (DASH) Trial. Am. J. Clin. Nutr. 2001, 74, 80-89. [PubMed]
54. Erlinger, T.P.; Miller, E.R., 3rd; Charleston, J.; Appel, L.J. Inflammation modifies the effects of a reduced-fat low-cholesterol diet on lipids: Results from the DASH-sodium trial. Circulation 2003, 108, 150-154. [CrossRef] [PubMed]
55. Michalsen, A.; Lehmann, N.; Pithan, C.; Knoblauch, N.T.; Moebus, S.; Kannenberg, F.; Binder, L.; Budde, T.; Dobos, G.J. Mediterranean diet has no effect on markers of inflammation and metabolic risk factors in patients with coronary artery disease. Eur. J. Clin. Nutr. 2006, 60, 478-485. [CrossRef] [PubMed]
56. Howard, B.V.; Van Horn, L.; Hsia, J.; Manson, J.E.; Stefanick, M.L.; Wassertheil-Smoller, S.; Kuller, L.H.; LaCroix, A.Z.; Langer, R.D.; Lasser, N.L. et al. Low-fat dietary pattern and risk of cardiovascular disease: The Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006, 295, 655-666. [CrossRef] [PubMed]
57. Ginsberg, H.N.; Kris-Etherton, P.; Dennis, B.; Elmer, P.J.; Ershow, A.; Lefevre, M.; Pearson, T.; Roheim, P.; Ramakrishnan, R.; Reed, R. et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: The DELTA Study, protocol 1. Arterioscler. Thromb. Vasc. Biol. 1998, 18, 441-449. [CrossRef] [PubMed]
58. Hepner, G.; Fried, R.; St Jeor, S.; Fusetti, L.; Morin, R. Hypocholesterolemic effect of yogurt and milk. Am. J. Clin. Nutr. 1979, 32, 19-24. [PubMed]
59. Rossouw, J.E.; Burger, E.M.; Van der Vyver, P.; Ferreira, J.J. The effect of skim milk, yoghurt, and full cream milk on human serum lipids. Am. J. Clin. Nutr. 1981, 34, 351-356. [PubMed]
60. Thompson, L.U.; Jenkins, D.J.; Amer, M.A.; Reichert, R.; Jenkins, A.; Kamulsky, J. The effect of fermented and unfermented milks on serum cholesterol. Am. J. Clin. Nutr. 1982, 36, 1106-1111. [PubMed]
61. Steinmetz, K.A.; Childs, M.T.; Stimson, C.; Kushi, L.H.; McGovern, P.G.; Potter, J.D.; Yamanaka, W.K. Effect of consumption of whole milk and skim milk on blood lipid profiles in healthy men. Am. J. Clin. Nutr. 1994, 59, 612-618. [PubMed]
62. Nestel, P.J.; Mellett, N.; Pally, S.; Wong, G.; Barlow, C.K.; Croft, K.; Mori, T.A.; Meikle, P.J. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br. J. Nutr. 2013, 110, 2242-2249. [CrossRef] [PubMed]
63. Mozaffarian, D. Dairy foods, dairy fat and cardiometabolic outcomes. In Proceedings of the American Society for Nutrition Annual Meeting Held in Conjunction with Experimental Biology, Boston, MA, USA, 27 March 2015. Available online: http://scientificsessions.nutrition.org/2015/satellitesessions/dairy/ (accessed on 14 July 2016).
64. Look, A.R.G.; Wing, R.R.; Bolin, P.; Brancati, F.L.; Bray, G.A.; Clark, J.M.; Coday, M.; Crow, R.S.; Curtis, J.M.; Egan, C.M. et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 2013, 369, 145-154.
65. Browning, J.D.; Baker, J.A.; Rogers, T.; Davis, J.; Satapati, S.; Burgess, S.C. Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction. Am. J. Clin. Nutr. 2011, 93, 1048-1052. [CrossRef] [PubMed]
66. Ebbeling, C.B.; Swain, J.F.; Feldman, H.A.; Wong, W.W.; Hachey, D.L.; Garcia-Lago, E.; Ludwig, D.S. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA 2012, 307, 2627-2634. [CrossRef] [PubMed]
67. Poutahidis, T.; Kleinewietfeld, M.; Smillie, C.; Levkovich, T.; Perrotta, A.; Bhela, S.; Varian, B.J.; Ibrahim, Y.M.; Lakritz, J.R.; Kearney, S.M. et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS ONE 2013, 8, e68596. [CrossRef] [PubMed]
68. Lennerz, B.S.; Alsop, D.C.; Holsen, L.M.; Stern, E.; Rojas, R.; Ebbeling, C.B.; Goldstein, J.M.; Ludwig, D.S. Effects of dietary glycemic index on brain regions related to reward and craving in men. Am. J. Clin. Nutr. 2013, 98, 641-647. [CrossRef] [PubMed]
69. Ludwig, D.S.; Friedman, M.I. Increasing adiposity: Consequence or cause of overeating? JAMA 2014, 311, 2167-2168. [CrossRef] [PubMed]
70. Shai, I.; Schwarzfuchs, D.; Henkin, Y.; Shahar, D.R.; Witkow, S.; Greenberg, I.; Golan, R.; Fraser, D.; Bolotin, A.; Vardi, H. et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N. Engl. J. Med. 2008, 359, 229-241. [CrossRef] [PubMed]
71. Mozaffarian, D.; Hao, T.; Rimm, E.B.; Willett, W.C.; Hu, F.B. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392-2404. [CrossRef] [PubMed]
72. Smith, J.D.; Hou, T.; Ludwig, D.S.; Rimm, E.B.; Willett, W.; Hu, F.B.; Mozaffarian, D. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: Results from 3 prospective cohorts. Am. J. Clin. Nutr. 2015, 101, 1216-1224. [CrossRef] [PubMed]
73. Abargouei, A.S.; Janghorbani, M.; Salehi-Marzijarani, M.; Esmaillzadeh, A. Effect of dairy consumption on weight and body composition in adults: A systematic review and meta-analysis of randomized controlled clinical trials. Int. J. Obes. (Lond.) 2012, 36, 1485-1493. [CrossRef] [PubMed]
74. Berkey, C.S.; Rockett, H.R.; Willett, W.C.; Colditz, G.A. Milk, dairy fat, dietary calcium, and weight gain: A longitudinal study of adolescents. Arch. Pediatr. Adolesc. Med. 2005, 159, 543-550. [CrossRef] [PubMed]
75. Huh, S.Y.; Rifas-Shiman, S.L.; Rich-Edwards, J.W.; Taveras, E.M.; Gillman, M.W. Prospective association between milk intake and adiposity in preschool-aged children. J. Am. Diet. Assoc. 2010, 110, 563-570. [CrossRef] [PubMed]
76. Noel, S.E.; Ness, A.R.; Northstone, K.; Emmett, P.; Newby, P.K. Milk intakes are not associated with percent body fat in children from ages 10 to 13 years. J. Nutr. 2011, 141, 2035-2041. [CrossRef] [PubMed]
77. Noel, S.E.; Ness, A.R.; Northstone, K.; Emmett, P.; Newby, P.K. Associations between flavored milk consumption and changes in weight and body composition over time: Differences among normal and overweight children. Eur. J. Clin. Nutr. 2013, 67, 295-300. [CrossRef] [PubMed]
78. Scharf, R.J.; Demmer, R.T.; DeBoer, M.D. Longitudinal evaluation of milk type consumed and weight status in preschoolers. Arch. Dis. Child. 2013, 98, 335-340. [CrossRef] [PubMed]
79. Rorive, M.; Letiexhe, M.R.; Scheen, A.J.; Ziegler, O. Obesity and type 2 diabetes. Rev. Med. Liege 2005, 60, 374-382. [PubMed]
80. Sluijs, I.; Forouhi, N.G.; Beulens, J.W.; van der Schouw, Y.T.; Agnoli, C.; Arriola, L.; Balkau, B.; Barricarte, A.; Boeing, H.; Bueno-de-Mesquita, H.B. et al. The amount and type of dairy product intake and incident type 2 diabetes: Results from the EPIC-InterAct Study. Am. J. Clin. Nutr. 2012, 96, 382-390. [CrossRef] [PubMed]
81. Mozaffarian, D.; Cao, H.; King, I.B.; Lemaitre, R.N.; Song, X.; Siscovick, D.S.; Hotamisligil, G.S. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: A cohort study. Ann. Intern Med. 2010, 153, 790-799. [CrossRef] [PubMed]
82. Astrup, A. Cheese and metabolic diseases. In Proceedings of the Federation of European Nutrition Societies 12th European Nutrition Conference, Berlin, Germany, 20-23 October 2015. Available online: http://www. fensberlin2015.org/?seccion=programme (accessed on 14 July 2016).
83. Soedamah-Muthu, S.S.; Ding, E.L.; Al-Delaimy, W.K.; Hu, F.B.; Engberink, M.F.; Willett, W.C.; Geleijnse, J.M. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011, 93, 158-171. [CrossRef] [PubMed]
84. Benatar, J.R.; Sidhu, K.; Stewart, R.A. Effects of high and low fat dairy food on cardio-metabolic risk factors: A meta-analysis of randomized studies. PLoS ONE 2013, 8, e76480. [CrossRef] [PubMed]
85. Thorning, T.K.; Raziani, F.; Bendsen, N.T.; Astrup, A.; Tholstrup, T.; Raben, A. Diets with high-fat cheese, high-fat meat, or carbohydrate on cardiovascular risk markers in overweight postmenopausal women: A randomized crossover trial. Am. J. Clin. Nutr. 2015, 102, 573-581. [CrossRef] [PubMed]
86. Nilsen, R.; Hostmark, A.T.; Haug, A.; Skeie, S. Effect of a high intake of cheese on cholesterol and metabolic syndrome: Results of a randomized trial. Food Nutr. Res. 2015, 59, 27651. [CrossRef] [PubMed]
87. Schlienger, J.L.; Paillard, F.; Lecerf, J.M.; Romon, M.; Bonhomme, C.; Schmitt, B.; Donazzolo, Y.; Defoort, C.; Mallmann, C.; Le Ruyet, P. et al. Effect on blood lipids of two daily servings of Camembert cheese. An intervention trial in mildly hypercholesterolemic subjects. Int. J. Food Sci. Nutr. 2014, 65, 1013-1018. [CrossRef] [PubMed]
88. Hjerpsted, J.; Leedo, E.; Tholstrup, T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am. J. Clin. Nutr. 2011, 94, 1479-1484. [CrossRef] [PubMed]
89. De Goede, J.; Geleijnse, J.M.; Ding, E.L.; Soedamah-Muthu, S.S. Effect of cheese consumption on blood lipids: A systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. 2015, 73, 259-275. [CrossRef] [PubMed]
90. Lorenzen, J.K.; Jensen, S.K.; Astrup, A. Milk minerals modify the effect of fat intake on serum lipid profile: Results from an animal and a human short-term study. Br. J. Nutr. 2014, 111, 1412-1420. [CrossRef] [PubMed]
91. Soerensen, K.V.; Thorning, T.K.; Astrup, A.; Kristensen, M.; Lorenzen, J.K. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am. J. Clin. Nutr. 2014, 99, 984-991. [CrossRef] [PubMed]
92. Ralston, R.A.; Lee, J.H.; Truby, H.; Palermo, C.E.; Walker, K.Z. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Hum. Hypertens. 2012, 26, 3-13. [CrossRef] [PubMed]
93. Soedamah-Muthu, S.S.; Verberne, L.D.; Ding, E.L.; Engberink, M.F.; Geleijnse, J.M. Dairy consumption and incidence of hypertension: A dose-response meta-analysis of prospective cohort studies. Hypertension 2012, 60, 1131-1137. [CrossRef] [PubMed]
94. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Dairy products and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 2013, 98, 1066-1083. [CrossRef] [PubMed]
95. Tong, X.; Dong, J.Y.; Wu, Z.W.; Li, W.; Qin, L.Q. Dairy consumption and risk of type 2 diabetes mellitus: A meta-analysis of cohort studies. Eur. J. Clin. Nutr. 2011, 65, 1027-1031. [CrossRef] [PubMed]
96. Gao, D.; Ning, N.; Wang, C.; Wang, Y.; Li, Q.; Meng, Z.; Liu, Y.; Li, Q. Dairy products consumption and risk of type 2 diabetes: Systematic review and dose-response meta-analysis. PLoS ONE 2013, 8, e73965. [CrossRef] [PubMed]
97. Aune, D.; Lau, R.; Chan, D.S.; Vieira, R.; Greenwood, D.C.; Kampman, E.; Norat, T. Dairy products and colorectal cancer risk: A systematic review and meta-analysis of cohort studies. Ann. Oncol. 2012, 23, 37-45. [CrossRef] [PubMed]
98. Delplanque, B. Dairy fat for infant formula: History and new evaluaiton of impact on brain DHA levels in animals. In Proceedings of the European Federation for the Science and Technology of Lipids 12th Euro Fed Lipids Congress, Montpellier, France, 14-17 September 2014. Available online: http://www.eurofedlipid.org/meetings/archive/montpellier2014/ (accessed on 14 July 2016).
99. Delplanque, B.; Gibson, R.; Koletzko, B.; Lapillonne, A.; Strandvik, B. Lipid Quality in Infant Nutrition: Current Knowledge and Future Opportunities. J. Pediatr. Gastroenterol. Nutr. 2015, 61, 8-17. [CrossRef] [PubMed]
100. Ailhaud, G.; Massiera, F.; Weill, P.; Legrand, P.; Alessandri, J.M.; Guesnet, P. Temporal changes in dietary fats: Role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog. Lipid Res. 2006, 45, 203-236. [CrossRef] [PubMed]
101. Guesnet, P.; Alessandri, J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS)—Implications for dietary recommendations. Biochimie 2011, 93, 7-12. [CrossRef] [PubMed]
102. Uauy, R.D.; Birch, D.G.; Birch, E.E.; Tyson, J.E.; Hoffman, D.R. Effect of dietary omega-3 fatty acids on retinal function of very-low-birth-weight neonates. Pediatr. Res. 1990, 28, 485-492. [CrossRef] [PubMed]
103. Ailhaud, G.; Guesnet, P. Fatty acid composition of fats is an early determinant of childhood obesity: A short review and an opinion. Obes. Rev. 2004, 5, 21-26. [CrossRef] [PubMed]
104. Ailhaud, G.; Guesnet, P.; Cunnane, S.C. An emerging risk factor for obesity: Does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr. 2008, 100, 461-470. [CrossRef] [PubMed]
105. Clark, K.J.; Makrides, M.; Neumann, M.A.; Gibson, R.A. Determination of the optimal ratio of linoleic acid to alpha-linolenic acid in infant formulas. J. Pediatr. 1992, 120, S151-S158. [CrossRef]
106. Pedersen, L.; Lauritzen, L.; Brasholt, M.; Buhl, T.; Bisgaard, H. Polyunsaturated fatty acid content of mother’s milk is associated with childhood body composition. Pediatr. Res. 2012, 72, 631-636. [CrossRef] [PubMed]
107. Lehner, F.; Demmelmair, H.; Roschinger, W.; Decsi, T.; Szasz, M.; Adamovich, K.; Arnecke, R.; Koletzko, B. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J. Lipid Res. 2006, 47, 404-411. [CrossRef] [PubMed]
108. Jamieson, E.C.; Farquharson, J.; Logan, R.W.; Howatson, A.G.; Patrick, W.J.; Weaver, L.T.; Cockburn, F. Infant cerebellar gray and white matter fatty acids in relation to age and diet. Lipids 1999, 34, 1065-1071. [CrossRef] [PubMed]
109. Campoy, C.; Escolano-Margarit, M.V.; Anjos, T.; Szajewska, H.; Uauy, R. Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. Br. J. Nutr. 2012, 107 (Suppl. 2), S85-S106. [CrossRef] [PubMed]
110. Makrides, M.; Gibson, R.A.; McPhee, A.J.; Collins, C.T.; Davis, P.G.; Doyle, L.W.; Simmer, K.; Colditz, P.B.; Morris, S.; Smithers, L.G. et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: A randomized controlled trial. JAMA 2009, 301, 175-182. [CrossRef] [PubMed]
111. Jensen, C.L.; Voigt, R.G.; Llorente, A.M.; Peters, S.U.; Prager, T.C.; Zou, Y.L.; Rozelle, J.C.; Turcich, M.R.; Fraley, J.K.; Anderson, R.E. et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J. Pediatr. 2010, 157, 900-905. [CrossRef] [PubMed]
112. Bourre, J.M.; Francois, M.; Youyou, A.; Dumont, O.; Piciotti, M.; Pascal, G.; Durand, G. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 1989, 119, 1880-1892. [PubMed]
113. Bourre, J.M.; Piciotti, M.; Dumont, O.; Pascal, G.; Durand, G. Dietary linoleic acid and polyunsaturated fatty acids in rat brain and other organs. Minimal requirements of linoleic acid. Lipids 1990, 25, 465-472. [CrossRef] [PubMed]
114. Delplanque, B.; Du, Q.; Agnani, G.; Le Ruyet, P.; Martin, J.C. A dairy fat matrix providing alpha-linolenic acid (ALA) is better than a vegetable fat mixture to increase brain DHA accretion in young rats. Prostaglandins Leukot. Essent. Fatty Acids 2013, 88, 115-120. [CrossRef] [PubMed]
115. Delplanque, B.; Du, Q.; Leruyet, P.; Agnani, G.; Pages, N.; Gripois, D.; Ould-Hamouda, H.; Carayon, P.; Martin, J. Brain docosahexaenoic acid (DHA) levels of young rats are related to alpha-linolenic acid (ALA) levels and fat matrix of the diet: Impact of dairy fat. OCL 2011, 18, 293-296. [CrossRef]
116. Du, Q.; Martin, J.C.; Agnani, G.; Pages, N.; Leruyet, P.; Carayon, P.; Delplanque, B. Dairy fat blends high in alpha-linolenic acid are superior to n-3 fatty-acid-enriched palm oil blends for increasing DHA levels in the brains of young rats. J. Nutr. Biochem. 2012, 23, 1573-1582. [CrossRef] [PubMed]
117. Delplanque, B.; Du, Q.; Leruyet, P.; Martin, J.C. Better restauration of brain DHA with dairy-fat compared to vegetable blends in omega3-deficient rat. J. Arch. Pediatr. 2014, 21, 793. [CrossRef]
118. Rolland, V.; Roseau, S.; Fromentin, G.; Nicolaidis, S.; Tome, D.; Even, P.C. Body weight, body composition, and energy metabolism in lean and obese Zucker rats fed soybean oil or butter. Am. J. Clin. Nutr. 2002, 75, 21-30. [PubMed]
119. Bendixen, H.; Flint, A.; Raben, A.; Hoy, C.E.; Mu, H.; Xu, X.; Bartels, E.M.; Astrup, A. Effect of 3 modified fats and a conventional fat on appetite, energy intake, energy expenditure, and substrate oxidation in healthy men. Am. J. Clin. Nutr. 2002, 75, 47-56. [PubMed]
120. Jones, P.J. Dietary linoleic, alpha-linolenic and oleic acids are oxidized at similar rates in rats fed a diet containing these acids in equal proportions. Lipids 1994, 29, 491-495. [CrossRef] [PubMed]
121. Tu, W.C.; Cook-Johnson, R.J.; James, M.J.; Muhlhausler, B.S.; Gibson, R.A. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot. Essent. Fatty Acids 2010, 83, 61-68. [CrossRef] [PubMed]
122. Cleland, L.G.; Gibson, R.A.; Pedler, J.; James, M.J. Paradoxical effect of n-3-containing vegetable oils on long-chain n-3 fatty acids in rat heart. Lipids 2005, 40, 995-998. [CrossRef] [PubMed]
123. Morise, A.; Combe, N.; Boue, C.; Legrand, P.; Catheline, D.; Delplanque, B.; Fenart, E.; Weill, P.; Hermier, D. Dose effect of alpha-linolenic acid on PUFA conversion, bioavailability, and storage in the hamster. Lipids 2004, 39, 325-334. [CrossRef] [PubMed]
124. Bach, A.C.; Babayan, V.K. Medium-chain triglycerides: An update. Am. J. Clin. Nutr. 1982, 36, 950-962. [PubMed]
125. Lamarche, B. Is It Time to Revisit Saturated fat Guidelines? Available online: https://www.dairynutrition. ca/symposium/2014/is-it-time-to-revisit-saturated-fat-guidelines (accessed on 14 July 2016).
126. Mozaffarian, D. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review. Circulation 2016, 133, 187-225. [CrossRef] [PubMed]
127. Dietary Guidelines for Americans, 2010. Available online: http://health.gov/dietaryguidelines/dga2010/ dietaryguidelines2010.pdf (accessed on 27 July 2016).
128. The Affordable Care Act. Available online: http://www.hhs.gov/healthcare/about-the-law/index.html (accessed on 27 July 2016).
129. National School Lunch Program. Available online: http://www.fns.usda.gov/nslp/national-school-lunchprogram-nslp (accessed on 27 July 2016).
130. Chandon, P.; Wansink, B. Does food marketing need to make us fat? A review and solutions. Nutr. Rev. 2012, 70, 571-593. [CrossRef] [PubMed]
131. Kratz, M.; Marcovina, S.; Nelson, J.E.; Yeh, M.M.; Kowdley, K.V.; Callahan, H.S.; Song, X.; Di, C.; Utzschneider, K.M. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not beta-cell function in humans. Am. J. Clin. Nutr. 2014, 99, 1385-1396. [CrossRef] [PubMed]